Lung transplantation in Turkey achieves a 1-year survival rate of 85%, aligning with international ISHLT standards. Long-term outcomes remain strong, with 5-year survival reaching 68.4% at specialized JCI-accredited centers like Medipol Mega University Hospital. Success relies on advanced ECMO support and bilateral surgical techniques.
- One-year survival: Approximately 85% of patients survive the first year following the procedure.
- Five-year survival: Experienced Turkish centers report long-term survival rates between 68.4% and 75%.
- Ten-year projection: Long-term data suggests a 50% survival rate a decade after transplantation.
- Conditional survival: Patients surpassing the first year show a 3-year survival rate of 84.2%.
Bookimed Expert Insight: While public hospitals face longer wait times, private institutions like Medipol Mega or Memorial Bahçelievler maintain high patient volumes, serving over 1,000,000 patients annually. These facilities often utilize `extended criteria` donors to reduce waitlist mortality without compromising 1-year survival outcomes. For international patients, the infrastructure at these JCI-accredited hubs ensures success rates that mirror top-tier US and European programs.
Patient Consensus: Patients often report a full recovery within 2 years, reaching milestones like breathing without oxygen after double lung transplants. Many emphasize that long-term survival depends heavily on strict compliance with follow-up care and immunosuppression protocols during the first critical year.